Skip to main content
NIH funding notice RFA-CA-20-003

Limited Competition: Biospecimen Bank to Support NCI Early-Phase and Experimental Clinical Trials (U24 Clinical Trials Not Allowed)

Closed on January 2, 2020.

Posted
November 12, 2019
Close date
January 2, 2020
Activity codes
U24
Institutes taking part
NCI

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page names no earlier notice: it is new, or it does not say.

Replaced by RFA-CA-28-004.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,532,382 in first-year total cost, median $2,532,382.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 SRB-5 (M2)]1

Most frequent institutions

  1. RESEARCH INST NATIONWIDE CHILDREN'S HOSP1
Competing awards under RFA-CA-20-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank1U24CA254445-01NICOL, KATHLEENRAMIREZ MILAN, NILSA DEL CARMENRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH$2,532,382ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-CA-20-003: Limited Competition: Biospecimen Bank to Support NCI Early-Phase and Experimental Clinical Trials (U24 Clinical Trials Not Allowed) | ScienceDex | ConductScience